Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: resembling (46)

Blood culture sampling policy April 2022 v8

Description: Blood Culture Sampling Policy for Adult and Paediatric Patients Trust reference Description Version number 8.0 This policy lists indications for
Url: /Media/UHS-website-2019/Docs/Policies/Blood-culture-sampling-policy-April-2022-v8.pdf

Palliative care for people with CF - patient information

Description: We've written this factsheet to explain how the palliative care team can help and support you.
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Palliative-care-for-people-with-CF-2325-PIL.pdf

NIHR_RTB_PIS-ICF_v5.0_04APR2024_Localised

Description: PARTICIPANT INFORMATION SHEET The NIHR BioResource Research Tissue Bank Version 5.0 04th April 2024 *If you require this information to
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-PIS-ICF-v5.0-04APR2024-Localised.pdf

Capecitabine-Cisplatin-Trastuzumab

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE-CISPLATIN-TRASTUZUMAB Regimen • Gastrointestinal (Upper) Cancer – Capecitabine-Cisplatin-Trastuzumab Indication • Trastuzumab, in combination with capecitabine
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Trastuzumab.pdf

NIHR_RTB_PIS-ICF_v5.0_04APR2024_Localised.cleaned

Description: PARTICIPANT INFORMATION SHEET The NIHR BioResource Research Tissue Bank Version 5.0 04th April 2024 *If you require this information to
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-PIS-ICF-v5.0-04APR2024-Localised.cleaned.pdf

AmB LEAM (split)-Lomustine-Cytarabine-Etoposide-Melphalan

Description: Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LEAM-split-Lomustine-Cytarabine-Etoposide-Melphalan.pdf

NIHR BioBank participant info sheet_v4

Description: PARTICIPANT INFORMATION SHEET The NIHR BioResource Research Tissue Bank Version 4.1 15th March 2023 *If you require this information to
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-BioBank-participant-info-sheet-v4.pdf

NIHR_RTB_PIS-ICF_v4.1_15Mar2023Localised

Description: PARTICIPANT INFORMATION SHEET The NIHR BioResource Research Tissue Bank Version 4.1 15th March 2023 *If you require this information to
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-PIS-ICF-v4.1-15Mar2023Localised.pdf

NIHR_RTB_PIS-ICF_v4.1_15Mar2023Localised

Description: 2 PARTICIPANT INFORMATION SHEET The NIHR BioResource Research Tissue Bank Version 4.1 15th March 2023 *If you require this information
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-PIS-ICF-v4.1-15Mar2023Localised.docx

InP-ICE-Carboplatin-Etoposide-Ifosfamide

Description: Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE (ICE) Inpatient Regimen Regimen • Lymphoma – InP-ICE-Carboplatin-Etoposide-Ifosfamide Indication • Non Hodgkin’s Lymphoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-ICE-Carboplatin-Etoposide-Ifosfamide.pdf

141 to 150 of 757

Previous … 13 14 15 16 17 … Next